本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Arcutis Biotherapeutics Inc.

15.24
+0.59004.03%
盘后15.300.0600+0.39%19:58 EDT
成交量:156.60万
成交额:2,379.50万
市值:18.08亿
市盈率:-13.16
高:15.58
开:14.75
低:14.74
收:14.65
数据加载中...
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/10

重要事件披露

Form 8-K - Current report
2024/03/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities